Anti-Human EGFR Therapeutic Antibody (H225)

This antibody that binds to human epidermal growth factor receptor is a humanized form of cetuximab and may inhibit binding of the epidermal growth factor to the EGF receptor as an antagonist of in vivo EGF-stimulated tyrosine kinase activity.
Supplier Creative Biolabs
Product # TAB-297MZ
Pricing Inquiry
Type Humanized antibody
Applications Enzyme-linked Immunosorbent Assay, Western Blot
Host Human
Target EGFR (Epidermal growth factor receptor, also known as ErbB-1, HER1)
Feedback